Anthony Davies on the first ever episode of Phacilitate: Talks

May 28, 2020

Categories

Anthony Davies, CEO, looking serious at summer retreat

CEO Anthony Davies had the distinct honor of being on the panel for the inaugural episode of Phacilitate: Talks, a socially-distanced podcast for the Cell & Gene Therapy space.

Via Insights Bio: "Challenges and benefits in harnessing platform processes for viral vector manufacture"

"FDA's CBER Issues Final Guidance For CAR-T Cell Products" by Anne Lamontagne and Wendy Liang

Brent Morse and Nate Manley on "FDA's Updated Guidance On Human Genome Editing"

Brent Morse and Amanda Mack on "Considerations for development of gene-edited PSC-based therapies"

Join the Quarter Horse Newsletter

We’ll send you a quarterly newsletter all things DHC!

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.